CliffBio
small molecule

METHOCARBAMOL AND ASPIRIN

ASPIRIN; METHOCARBAMOL

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETHOCARBAMOL AND ASPIRIN
Active ingredientASPIRIN; METHOCARBAMOL
Strength325MG;400MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 1988
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METHOCARBAMOL AND ASPIRIN patent cliff — loss of exclusivity — | CliffBio